Alzheimer's Reading Room
Cure Alzheimer’s Fund recently awarded Dr. Nicholas Seeds, with the
University of Colorado School of Medicine, a $100,000 grant for novel research
on Alzheimer’s disease, which affects 5.2 million Americans and their families
and is the most common cause of dementia in the elderly.
Researcher to Investigate Alzheimer’s Disease Treatments
Cure Alzheimer’s Fund recently awarded Dr. Nicholas Seeds, with the
University of Colorado School of Medicine, a $100,000 grant for novel research
on Alzheimer’s disease, which affects 5.2 million Americans and their families
and is the most common cause of dementia in the elderly.
“This research has the potential to unlock a new understanding of the causes
and risk factors for Alzheimer’s disease,” said Tim Armour , President and CEO
of Cure Alzheimer’s Fund. “It could bring us a step closer to ultimately
stopping or even reversing its effects.”
The grant will allow Seeds’ lab to continue research on neuroserpin, a protease
inhibitor in the brain that is a possible contributor to the onset of
Alzheimer’s. The lab’s research on mice shows that the deletion of the
neuroserpin gene can lead to a reduction of Amyloid-Beta, a protein in the
brain that is commonly linked to Alzheimer’s disease, and may result in
restoration of normal cognitive behavior. Most importantly, Seeds aims to
identify small molecules that block neuroserpin. The goal is to create
Alzheimer’s therapeutics for future patient studies.
“With university budgets stretched thin, the Fund’s support is critical in
helping further this important research on this devastating disease,” said
Seeds, a Professor of Biochemistry and Molecular Genetics at the Colorado
medical school.
Cure Alzheimer’s Fund has no endowment and passes funds raised directly to
selected research. The Fund has no financial or intellectual property interest
in the research funded, and will make known the results of all funded research
as soon as possible. Over the past ten years the federal government’s
investment in Alzheimer’s research and education has decreased. Since it’s
inception in 2004, Cure Alzheimer’s Fund has raised more than $15 million,
investing all of it directly into research.
“Research is key to finding a cure and better treatments for Alzheimer’s
disease,” said Armour. “With the advances in technology over the past 10
years, great strides have been made in Alzheimer’s research and we are on the
cusp of major breakthroughs. Cure Alzheimer’s Fund believes the pioneering work
of the University of Colorado School of Medicine researchers and others could
bring us one step closer to our goal of finding a cure.”
About Cure Alzheimer's Fund
Cure Alzheimer's Fund™ is a 501c3 public charity whose mission is to fund
research with the highest probability of slowing, stopping or reversing
Alzheimer's disease. Cure Alzheimer’s Fund is characterized by a venture
approach to philanthropy, which targets funding to specific research
objectives. All expenses and overhead is paid for by its founders and all
contributions go directly to research. The Foundation has no financial or
intellectual property interest in the research funded, and will make known the
results of all funded research as soon as possible. Cure Alzheimer’s Fund is a
national organization with offices in Boston and Pittsburgh. For more
information, visit www.curealzfund.org.
Media Contacts: David Roscow, 703-276-2772 x 21, Cure Alzheimer’s Fund
Dan Meyers, 303-724-5377, University of Colorado School of Medicine
More About the Alzheimer's Reading Room
- Test Your Self for Alzheimer's Dementia (5 Best Self Assessment Tests)
- Alzheimer's Disease Statistics
- What is Alzheimer's? What are the Eight Types of Dementia?
- Alzheimer's Dementia Caregiving -- Advice and Insight
- Does the Combination of Aricept and Namenda Help Slow the Rate of Decline in Alzheimer's Patients
- Communicating in Alzheimer's World
- Is it Really Alzheimer's or Something Else?
- 2010 Alzheimer's Disease Facts and Figures
- 60 Good Reasons to Subscribe to the Alzheimer's Reading Room
Bob DeMarco is the editor of the Alzheimer's Reading Room and an Alzheimer's caregiver. Bob has written more than 1,400 articles with more than 9,000 links on the Internet. Bob resides in Delray Beach, FL.
 The Alzheimer's Action Plan |  300 Tips for Making Life Easier |
Original content Bob DeMarco, the Alzheimer's Reading Room